IBDEI13B ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17703,0)
 ;;=Z98.82^^61^791^14
 ;;^UTILITY(U,$J,358.3,17703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17703,1,3,0)
 ;;=3^Breast Implant Status
 ;;^UTILITY(U,$J,358.3,17703,1,4,0)
 ;;=4^Z98.82
 ;;^UTILITY(U,$J,358.3,17703,2)
 ;;=^5063747
 ;;^UTILITY(U,$J,358.3,17704,0)
 ;;=B37.3^^61^791^15
 ;;^UTILITY(U,$J,358.3,17704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17704,1,3,0)
 ;;=3^Candidiasis of Vulva & Vagina
 ;;^UTILITY(U,$J,358.3,17704,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,17704,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,17705,0)
 ;;=D06.9^^61^791^16
 ;;^UTILITY(U,$J,358.3,17705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17705,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Unspec
 ;;^UTILITY(U,$J,358.3,17705,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,17705,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,17706,0)
 ;;=D06.0^^61^791^17
 ;;^UTILITY(U,$J,358.3,17706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17706,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,17706,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,17706,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,17707,0)
 ;;=D06.1^^61^791^18
 ;;^UTILITY(U,$J,358.3,17707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17707,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,17707,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,17707,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,17708,0)
 ;;=A56.02^^61^791^19
 ;;^UTILITY(U,$J,358.3,17708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17708,1,3,0)
 ;;=3^Chlamydial Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,17708,1,4,0)
 ;;=4^A56.02
 ;;^UTILITY(U,$J,358.3,17708,2)
 ;;=^5000340
 ;;^UTILITY(U,$J,358.3,17709,0)
 ;;=N81.12^^61^791^22
 ;;^UTILITY(U,$J,358.3,17709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17709,1,3,0)
 ;;=3^Cystocele,Lateral
 ;;^UTILITY(U,$J,358.3,17709,1,4,0)
 ;;=4^N81.12
 ;;^UTILITY(U,$J,358.3,17709,2)
 ;;=^331535
 ;;^UTILITY(U,$J,358.3,17710,0)
 ;;=N81.11^^61^791^23
 ;;^UTILITY(U,$J,358.3,17710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17710,1,3,0)
 ;;=3^Cystocele,Midline
 ;;^UTILITY(U,$J,358.3,17710,1,4,0)
 ;;=4^N81.11
 ;;^UTILITY(U,$J,358.3,17710,2)
 ;;=^331534
 ;;^UTILITY(U,$J,358.3,17711,0)
 ;;=N81.10^^61^791^24
 ;;^UTILITY(U,$J,358.3,17711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17711,1,3,0)
 ;;=3^Cystocele,Unspec
 ;;^UTILITY(U,$J,358.3,17711,1,4,0)
 ;;=4^N81.10
 ;;^UTILITY(U,$J,358.3,17711,2)
 ;;=^5015838
 ;;^UTILITY(U,$J,358.3,17712,0)
 ;;=R87.614^^61^791^25
 ;;^UTILITY(U,$J,358.3,17712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17712,1,3,0)
 ;;=3^Cytologic Evidence of Malig on Smear of Cervix
 ;;^UTILITY(U,$J,358.3,17712,1,4,0)
 ;;=4^R87.614
 ;;^UTILITY(U,$J,358.3,17712,2)
 ;;=^5019672
 ;;^UTILITY(U,$J,358.3,17713,0)
 ;;=N87.9^^61^791^35
 ;;^UTILITY(U,$J,358.3,17713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17713,1,3,0)
 ;;=3^Dysplasia of Cervix Uteri,Unspec
 ;;^UTILITY(U,$J,358.3,17713,1,4,0)
 ;;=4^N87.9
 ;;^UTILITY(U,$J,358.3,17713,2)
 ;;=^5015877
 ;;^UTILITY(U,$J,358.3,17714,0)
 ;;=R30.0^^61^791^36
 ;;^UTILITY(U,$J,358.3,17714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17714,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,17714,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,17714,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,17715,0)
 ;;=N92.1^^61^791^39
 ;;^UTILITY(U,$J,358.3,17715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17715,1,3,0)
 ;;=3^Excessive/Frequent Menstruation w/ Irregular Cycle
